GH-axis standards

CJC-1295 No-DAC + Ipamorelin (blend) 5+5mg

Also indexed as Mod GRF (1-29) + Ipamorelin

SKUVP-CJC-IPA-55 TypePeptide blend Package5+5mg RUO
REFERENCE STANDARD
CJC-1295 No-DAC + Ipamorelin (blend) 5+5mg - VERIPHASE research peptide vial
Lot
26-0042
Label expiry (assigned)

Awaiting release

€64.99 €6.50 / mg

Testing in progress

0 of 6 checks

0 of 6 checks complete

Read the evidence publication policy Details ↓

Testing is in progress

One email after all required acceptance checks pass and the lot is commercially released.

EU-based catalogue Testing in progress Lot evidence pending

Research use only. Not for human or animal use. A binding research-use declaration is required to order.

About this reference material

A research blend pairing CJC-1295 No-DAC (Mod GRF 1-29) and Ipamorelin reference peptides in a single vial (5 mg of each) for comparative in-vitro reference workflows. Research use only - not for human or animal use.

Reference record

Primary identity
CJC-1295 No-DAC + Ipamorelin
Aliases
Mod GRF (1-29) + Ipamorelin
SKU
VP-CJC-IPA-55
Product type
Peptide blend
Package
5+5mg

Structured blend composition

ComponentReference aliasComponent amount
CJC-1295 No-DACMod GRF (1-29)5 mg
Ipamorelin—5 mg
Total package5+5mg

Analysis & documentation

CERTIFICATE OF ANALYSIS

Lot-specific evidence is published only after the source report and every result required by this product's test profile have been validated. Use the availability enquiry for release timing or documentation status.

Learn

Related reference materials